{ "item_title" : "Emerging Biomarkers in Bladder Cancer", "item_author" : [" Trinity Schell "], "item_description" : "Biomarkers play a crucial role in the diagnosis, prognosis, and treatment of bladder cancer. These indicators, ranging from genetic mutations to protein expressions, help in early detection and personalized management strategies. For instance, biomarkers like FGFR3 mutations and overexpression of proteins like CK20 have been identified as significant in bladder cancer pathology. They aid in stratifying patients based on risk and guiding treatment decisions, such as choosing between surgery, chemotherapy, or immunotherapy. Additionally, monitoring biomarker levels can track treatment response and predict recurrence, enhancing patient outcomes. As research advances, the identification of novel biomarkers promises to further refine diagnostic accuracy and therapeutic efficacy in bladder cancer management, ultimately aiming for improved survival rates and quality of life for patients. This book attempts to understand the role of biomarkers in bladder cancer detection and therapy and how such concepts have practical applications. This book will also provide interesting topics for research which interested readers can take up. It will help the readers in keeping pace with the rapid changes in this field.", "item_img_path" : "https://covers1.booksamillion.com/covers/bam/9/79/889/366/9798893660104_b.jpg", "price_data" : { "retail_price" : "154.00", "online_price" : "154.00", "our_price" : "154.00", "club_price" : "154.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }

Overview

Customers Also Bought

Details